drugset / Trial / NCT07449702
An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
Non-randomizedParallel-groupOpen-labelTreatment
Summary
An open-label extension (OLE) study to evaluate the long-term safety and efficacy of ORKA-001 in adult participants with moderate-to-severe plaque psoriasis, who previously participated in an Oruka Therapeutics sponsored study.
Timeline
- Start
- 2026-02-23
- Primary completion
- 2030-05
- Completion
- 2030-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ORKA-001 | Unknown | — | Subcutaneous |